This known link to renal function further supports the role of MYH9 as a genomic biomarker in CKD, although further studies in patients of European descent with CKD may be required to determine its suitability a biomarker across populations or should be limited to African Americans. The gene discussed is MYH9; the disease is chronic kidney disease.